Pedicle Screw FDA Status Irrelevant To Informed Consent, N.J. Court Finds
This article was originally published in The Gray Sheet
Executive Summary
Notifying patients of the FDA regulatory status of devices used in surgical procedures is non-essential to the informed consent process, according to a New Jersey appellate court
You may also be interested in...
Supreme Court Leaves FDA To Its Own Devices In Regulating Fraud Claims
The Supreme Court's Feb. 21 decision in Buckman Co. v. Plaintiffs Legal Committee defends off-label use as a vital "corollary" to FDA's regulatory scheme, while also investing sole authority in the agency to determine whether premarket submissions are fraudulent.
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.